Peetz Christopher bought MIRM
September 1, 2026 · Form 4 insider transaction
Peetz Christopher bought 30,000 shares of Mirum Pharmaceuticals, Inc. at $2.94 per share, a transaction worth $88.1K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
30,000
Price
$2.94
Total value
$88.1K
InsiderPeetz Christopher
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 1, 2026
Filing dateSeptember 3, 2026
Shares owned after224,440
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Includes 131 shares of Common Stock that were acquired by the Reporting Person on May 10, 2026, pursuant to the Issuer's Employee Stock Purchase Plan.